AI assistant
Sending…
Celldex Therapeutics, Inc. — Director's Dealing 2017
Oct 3, 2017
31801_dirs_2017-10-03_e6e0b6ed-f663-4b68-8f4b-c34ea6fa6e20.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Celldex Therapeutics, Inc. (CLDX)
CIK: 0000744218
Period of Report: 2017-10-03
Reporting Person: Heath-Chiozzi Margo (SVP of of Regulatory Affairs)
More from Celldex Therapeutics, Inc.
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Major Shareholding Notification
2026
May 6
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 29
Proxy Solicitation & Information Statement
2026
Apr 29
Regulatory Filings
2026
Apr 2
Regulatory Filings
2026
Apr 2
Regulatory Filings
2026
Apr 1
Major Shareholding Notification
2026
Mar 26